Primary immunodeficiency disorder caused by phosphoinositide 3–kinase ? deficiency - 06/11/18
Doi : 10.1016/j.jaci.2018.06.039
Georgios Sogkas, MD, PhD a 
, Mykola Fedchenko, MD b, Akshay Dhingra, MSc c, Alexandra Jablonka, MD a, Reinhold E. Schmidt, MD a, Faranaz Atschekzei, MD, PhD a
, Mykola Fedchenko, MD b, Akshay Dhingra, MSc c, Alexandra Jablonka, MD a, Reinhold E. Schmidt, MD a, Faranaz Atschekzei, MD, PhD a a Division of Immunology and Rheumatology, Hannover Medical University, Hannover, Germany
b Institute of Pathology, Hannover Medical University, Hannover, Germany
c Institute of Virology, Hannover Medical University, Hannover, Germany
| G.S. and A.J. received funding from the Young Academy Clinician/Scientist program of Hannover Medical School, Hannover, Germany. This project was supported by the German Center for Infection Research, DZIF TTU 07.801. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 5
P. 1650 - novembre 2018 Retour au numéro
Article précédent
- Fc?RI cross-linking and IL-3 protect human basophils from intrinsic apoptotic stress
- Lionel Rohner, Ramona Reinhart, Björn Hagmann, Andrea Odermatt, Annet Babirye, Thomas Kaufmann, Michaela Fux
- One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years
- Reem Ahmed Elfeky, Juliana M. Furtado-Silva, Robert Chiesa, Kanchan Rao, Persis Amrolia, Giovanna Lucchini, Kimberly Gilmour, Stuart Adams, Shahnaz Bibi, Austen Worth, Adrian J. Thrasher, Waseem Qasim, Paul Veys
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?